Interactions of cholecystokinin and dopamine in the nucleus accumbens.
Wang
R Y
RY
White
F J
FJ
Voigt
M M
MM
D000818:Animals; D002766:Cholecystokinin / Q000032:analysis / Q000494:pharmacology*; D004298:Dopamine / Q000032:analysis* / Q000494:pharmacology; D005971:Glutamates / Q000494:pharmacology; D018698:Glutamic Acid; D006801:Humans; D009714:Nucleus Accumbens / Q000187:drug effects* / Q000502:physiology; D010477:Perfusion; D011188:Potassium / Q000494:pharmacology; D011377:Proglumide / Q000494:pharmacology; D011954:Receptors, Dopamine / Q000032:analysis / Q000187:drug effects; D012559:Schizophrenia / Q000209:etiology; D012686:Septal Nuclei / Q000187:drug effects*
D005971:Glutamates; D011954:Receptors, Dopamine; D018698:Glutamic Acid; D002766:Cholecystokinin; D011377:Proglumide; D011188:Potassium; D004298:Dopamine